135 related articles for article (PubMed ID: 22156619)
1. Tissue transglutaminase: a novel therapeutic target in cerebral amyloid angiopathy.
Wilhelmus MM; de Jager M; Drukarch B
Neurodegener Dis; 2012; 10(1-4):317-9. PubMed ID: 22156619
[TBL] [Abstract][Full Text] [Related]
2. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
[TBL] [Abstract][Full Text] [Related]
3. Tissue transglutaminase colocalizes with extracellular matrix proteins in cerebral amyloid angiopathy.
de Jager M; van der Wildt B; Schul E; Bol JG; van Duinen SG; Drukarch B; Wilhelmus MM
Neurobiol Aging; 2013 Apr; 34(4):1159-69. PubMed ID: 23122413
[TBL] [Abstract][Full Text] [Related]
4. The blood clotting Factor XIIIa forms unique complexes with amyloid-beta (Aβ) and colocalizes with deposited Aβ in cerebral amyloid angiopathy.
de Jager M; Boot MV; Bol JG; Brevé JJ; Jongenelen CA; Drukarch B; Wilhelmus MM
Neuropathol Appl Neurobiol; 2016 Apr; 42(3):255-72. PubMed ID: 25871449
[TBL] [Abstract][Full Text] [Related]
5. Cerebral amyloid angiopathy.
Yamada M; Naiki H
Prog Mol Biol Transl Sci; 2012; 107():41-78. PubMed ID: 22482447
[TBL] [Abstract][Full Text] [Related]
6. Wild-type amyloid beta 1-40 peptide induces vascular smooth muscle cell death independently from matrix metalloprotease activity.
Blaise R; Mateo V; Rouxel C; Zaccarini F; Glorian M; Béréziat G; Golubkov VS; Limon I
Aging Cell; 2012 Jun; 11(3):384-93. PubMed ID: 22260497
[TBL] [Abstract][Full Text] [Related]
7. Extracellular matrix modulator lysyl oxidase colocalizes with amyloid-beta pathology in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis--Dutch type.
Wilhelmus MM; Bol JG; van Duinen SG; Drukarch B
Exp Gerontol; 2013 Feb; 48(2):109-14. PubMed ID: 23267843
[TBL] [Abstract][Full Text] [Related]
8. Deposition of amyloid β in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy.
Keable A; Fenna K; Yuen HM; Johnston DA; Smyth NR; Smith C; Al-Shahi Salman R; Samarasekera N; Nicoll JA; Attems J; Kalaria RN; Weller RO; Carare RO
Biochim Biophys Acta; 2016 May; 1862(5):1037-46. PubMed ID: 26327684
[TBL] [Abstract][Full Text] [Related]
9. Prenatal high-fat diet alters the cerebrovasculature and clearance of β-amyloid in adult offspring.
Hawkes CA; Gentleman SM; Nicoll JA; Carare RO
J Pathol; 2015 Mar; 235(4):619-31. PubMed ID: 25345857
[TBL] [Abstract][Full Text] [Related]
10. Tissue transglutaminase in Alzheimer's disease: involvement in pathogenesis and its potential as a therapeutic target.
Wilhelmus MM; de Jager M; Bakker EN; Drukarch B
J Alzheimers Dis; 2014; 42 Suppl 3():S289-303. PubMed ID: 24685636
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy.
Miners JS; Ashby E; Van Helmond Z; Chalmers KA; Palmer LE; Love S; Kehoe PG
Neuropathol Appl Neurobiol; 2008 Apr; 34(2):181-93. PubMed ID: 17973905
[TBL] [Abstract][Full Text] [Related]
12. Pin1, endothelial nitric oxide synthase, and amyloid-β form a feedback signaling loop involved in the pathogenesis of Alzheimer's disease, hypertension, and cerebral amyloid angiopathy.
Wang JZ; Zhu WD; Xu ZX; Du WT; Zhang HY; Sun XW; Wang XH
Med Hypotheses; 2014 Feb; 82(2):145-50. PubMed ID: 24332564
[TBL] [Abstract][Full Text] [Related]
13. Vascular basement membrane alterations and β-amyloid accumulations in an animal model of cerebral small vessel disease.
Held F; Morris AWJ; Pirici D; Niklass S; Sharp MMG; Garz C; Assmann A; Heinze HJ; Schreiber F; Carare RO; Schreiber S
Clin Sci (Lond); 2017 May; 131(10):1001-1013. PubMed ID: 28348005
[TBL] [Abstract][Full Text] [Related]
14. Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy.
Saito S; Yamamoto Y; Maki T; Hattori Y; Ito H; Mizuno K; Harada-Shiba M; Kalaria RN; Fukushima M; Takahashi R; Ihara M
Acta Neuropathol Commun; 2017 Apr; 5(1):26. PubMed ID: 28376923
[TBL] [Abstract][Full Text] [Related]
15. Cerebral amyloid angiopathy aggravates perivascular clearance impairment in an Alzheimer's disease mouse model.
Kim SH; Ahn JH; Yang H; Lee P; Koh GY; Jeong Y
Acta Neuropathol Commun; 2020 Nov; 8(1):181. PubMed ID: 33153499
[TBL] [Abstract][Full Text] [Related]
16. Cerebral amyloid angiopathy: major contributor or decorative response to Alzheimer's disease pathogenesis.
Castellani RJ; Smith MA; Perry G; Friedland RP
Neurobiol Aging; 2004; 25(5):599-602; discussion 603-4. PubMed ID: 15172735
[TBL] [Abstract][Full Text] [Related]
17. Cerebral amyloid angiopathy: pathogenetic mechanisms and link to dense amyloid plaques.
Kumar-Singh S
Genes Brain Behav; 2008 Feb; 7 Suppl 1():67-82. PubMed ID: 18184371
[TBL] [Abstract][Full Text] [Related]
18. Transglutaminases and transglutaminase-catalyzed cross-links colocalize with the pathological lesions in Alzheimer's disease brain.
Wilhelmus MM; Grunberg SC; Bol JG; van Dam AM; Hoozemans JJ; Rozemuller AJ; Drukarch B
Brain Pathol; 2009 Oct; 19(4):612-22. PubMed ID: 18673368
[TBL] [Abstract][Full Text] [Related]
19. Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease. Pro-CAA position statement.
Nicoll JA; Yamada M; Frackowiak J; Mazur-Kolecka B; Weller RO
Neurobiol Aging; 2004; 25(5):589-97; discussion 603-4. PubMed ID: 15172734
[TBL] [Abstract][Full Text] [Related]
20. Regional differences in the morphological and functional effects of aging on cerebral basement membranes and perivascular drainage of amyloid-β from the mouse brain.
Hawkes CA; Gatherer M; Sharp MM; Dorr A; Yuen HM; Kalaria R; Weller RO; Carare RO
Aging Cell; 2013 Apr; 12(2):224-36. PubMed ID: 23413811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
